SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001437749-18-021842
Filing Date
2018-12-10
Accepted
2018-12-10 16:50:06
Documents
14

Document Format Files

Seq Description Document Type Size
1 FORM 424B4 dmtp20181207_424b4.htm 424B4 2449915
2 targetrangestroke.jpg GRAPHIC 38422
3 bklevelsgraph.jpg GRAPHIC 70684
4 procineklk1.jpg GRAPHIC 20911
5 klk1strokegraph.jpg GRAPHIC 15433
6 therapygraph.jpg GRAPHIC 50373
7 strokegraph.jpg GRAPHIC 50406
8 klk1andckd.jpg GRAPHIC 21077
9 linegraphdm199.jpg GRAPHIC 16837
10 graphdm199.jpg GRAPHIC 61152
11 klk1treatmentcombo.jpg GRAPHIC 38927
12 klk1phaseiii.jpg GRAPHIC 31315
13 img01.jpg GRAPHIC 24746
14 dmt.jpg GRAPHIC 13345
  Complete submission text file 0001437749-18-021842.txt   3077281
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-228313 | Film No.: 181226696
SIC: 2834 Pharmaceutical Preparations